Department of Immunology
Browse by
Collections in this community
Recent Submissions
-
Novel FFAR2 agonist prevents development of type 1 diabetes in C57BL/6 mice
(John Wiley and Sons, 2024) -
Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease
(Lausanne: Frontiers Media SA, 2024) -
Semaglutid kao potentan aktivator antitumorskog imunskog odgovora u karcinomu dojke / Семаглутид као потентан активатор антитуморског имунског одговора у карциному дојке
(Beograd, Srbija: Srpska akademija nauka i umetnosti, 2024) -
Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes
(Elsevier Science Ltd, 2002) -
Anti-Neuroinflammatory Effects of a Novel Bile Acid Derivative
(Basel: MDPI, 2024) -
IMMUnity Unveiled: A Translational NETwork for tackling PARKinson's Disease – IMMUPARKNET
(Research Limited on behalf of the European Commission, 2024) -
Antimelanoma Effects of Alchemilla vulgaris: A Comprehensive In Vitro and In Vivo Study
(Basel: MDPI, 2024) -
Bipyraloxifene – a modified raloxifene vector against triple-negative breast cancer
(The Royal Society of Chemistry, 2024) -
Novel triphenyltin(iv) compounds with carboxylato N-functionalized 2-quinolones as promising potential anticancer drug candidates: in vitro and in vivo evaluation
(Cambridge: The Royal Society of Chemistry, 2024) -
NRF2 plays a crucial role in the tolerogenic effect of ethyl pyruvate on dendritic cells
(Basel: MDPI, 2024) -
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo
(American Chemical Society, 2024)